Abivax Appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
Marc's appointment bolsters Abivax's position as a leader in the field of chronic inflammatory bowel diseasesCorinna zur Bonsen-Thomas steps down as acting Chair and remains a Board MemberProf. Hartmut